Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cervical Vertebrae | 2 | 2019 | 42 | 0.690 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2019 | 4 | 0.690 |
Why?
|
| Osteoradionecrosis | 1 | 2019 | 5 | 0.690 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2019 | 5 | 0.690 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 55 | 0.670 |
Why?
|
| Spinal Fusion | 1 | 2019 | 42 | 0.660 |
Why?
|
| Vertebral Artery | 1 | 2017 | 8 | 0.600 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2017 | 30 | 0.590 |
Why?
|
| Wounds, Gunshot | 1 | 2017 | 34 | 0.570 |
Why?
|
| Neurosurgical Procedures | 5 | 2017 | 98 | 0.480 |
Why?
|
| Multicenter Studies as Topic | 2 | 2015 | 93 | 0.450 |
Why?
|
| Coma | 1 | 2013 | 6 | 0.450 |
Why?
|
| Electroencephalography | 1 | 2013 | 71 | 0.440 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2012 | 18 | 0.430 |
Why?
|
| Arteriovenous Fistula | 1 | 2012 | 14 | 0.430 |
Why?
|
| Analgesics | 2 | 2016 | 126 | 0.410 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 467 | 0.390 |
Why?
|
| Healthcare Common Procedure Coding System | 1 | 2010 | 1 | 0.380 |
Why?
|
| Relative Value Scales | 1 | 2010 | 2 | 0.380 |
Why?
|
| Reimbursement Mechanisms | 1 | 2010 | 11 | 0.380 |
Why?
|
| Humans | 28 | 2020 | 29259 | 0.360 |
Why?
|
| Paraplegia | 1 | 2009 | 6 | 0.350 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2009 | 6 | 0.350 |
Why?
|
| Spinal Cord Compression | 1 | 2009 | 8 | 0.350 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2009 | 7 | 0.350 |
Why?
|
| Pain, Postoperative | 2 | 2012 | 175 | 0.350 |
Why?
|
| Diskectomy | 1 | 2009 | 13 | 0.350 |
Why?
|
| Spinal Nerves | 1 | 2009 | 65 | 0.330 |
Why?
|
| Neurosurgery | 3 | 2017 | 34 | 0.320 |
Why?
|
| Postoperative Complications | 2 | 2010 | 672 | 0.310 |
Why?
|
| Phantom Limb | 1 | 2007 | 4 | 0.310 |
Why?
|
| Pain | 2 | 2010 | 282 | 0.300 |
Why?
|
| Ketamine | 1 | 2007 | 20 | 0.300 |
Why?
|
| Amputation | 1 | 2007 | 37 | 0.300 |
Why?
|
| Radiosurgery | 1 | 2010 | 322 | 0.290 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2005 | 26 | 0.270 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 36 | 0.270 |
Why?
|
| Spinal Cord | 2 | 2008 | 139 | 0.270 |
Why?
|
| Pain Threshold | 1 | 2005 | 95 | 0.260 |
Why?
|
| Dura Mater | 2 | 2017 | 14 | 0.260 |
Why?
|
| Stroke | 3 | 2015 | 549 | 0.260 |
Why?
|
| Treatment Outcome | 6 | 2019 | 3114 | 0.260 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 73 | 0.240 |
Why?
|
| Adult | 8 | 2019 | 8471 | 0.230 |
Why?
|
| Male | 13 | 2019 | 17883 | 0.230 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2002 | 4 | 0.210 |
Why?
|
| Middle Aged | 12 | 2019 | 10879 | 0.210 |
Why?
|
| Laminectomy | 1 | 2002 | 16 | 0.210 |
Why?
|
| Spine | 1 | 2002 | 38 | 0.210 |
Why?
|
| Intraoperative Complications | 1 | 2002 | 49 | 0.210 |
Why?
|
| Hypotension | 1 | 2002 | 47 | 0.200 |
Why?
|
| Meningeal Neoplasms | 2 | 2020 | 46 | 0.200 |
Why?
|
| Meningioma | 2 | 2020 | 51 | 0.200 |
Why?
|
| Orbital Neoplasms | 1 | 2020 | 1 | 0.180 |
Why?
|
| Analgesia, Epidural | 2 | 2012 | 50 | 0.170 |
Why?
|
| Gastric Bypass | 1 | 2019 | 28 | 0.170 |
Why?
|
| Needs Assessment | 1 | 2019 | 66 | 0.170 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 208 | 0.170 |
Why?
|
| Reoperation | 1 | 2019 | 203 | 0.170 |
Why?
|
| United States | 7 | 2017 | 3649 | 0.160 |
Why?
|
| Brain Neoplasms | 3 | 2013 | 587 | 0.160 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2020 | 190 | 0.160 |
Why?
|
| Analysis of Variance | 3 | 2012 | 454 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 1221 | 0.150 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 525 | 0.150 |
Why?
|
| Tissue Adhesives | 1 | 2017 | 5 | 0.150 |
Why?
|
| Pain Measurement | 3 | 2012 | 365 | 0.150 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2017 | 7 | 0.150 |
Why?
|
| Female | 14 | 2017 | 18256 | 0.150 |
Why?
|
| Occult Blood | 2 | 2007 | 9 | 0.150 |
Why?
|
| Hydrogels | 1 | 2017 | 103 | 0.140 |
Why?
|
| Intracranial Aneurysm | 1 | 2017 | 55 | 0.140 |
Why?
|
| Pelvic Pain | 1 | 2016 | 18 | 0.140 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2016 | 20 | 0.140 |
Why?
|
| Amines | 1 | 2016 | 22 | 0.140 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 95 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2017 | 154 | 0.140 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 74 | 0.130 |
Why?
|
| Time Factors | 4 | 2012 | 2007 | 0.130 |
Why?
|
| Therapeutic Equipoise | 1 | 2015 | 1 | 0.130 |
Why?
|
| Physicians | 1 | 2017 | 135 | 0.130 |
Why?
|
| Aged | 9 | 2017 | 9520 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2014 | 47 | 0.120 |
Why?
|
| Thrombolytic Therapy | 2 | 2015 | 59 | 0.120 |
Why?
|
| Adolescent | 2 | 2019 | 3267 | 0.120 |
Why?
|
| Receptors, Somatostatin | 1 | 2013 | 5 | 0.120 |
Why?
|
| Colorectal Neoplasms | 2 | 2007 | 208 | 0.120 |
Why?
|
| Hemangiopericytoma | 1 | 2013 | 6 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2019 | 1313 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 2014 | 46 | 0.120 |
Why?
|
| Aneurysm, Ruptured | 2 | 2017 | 26 | 0.120 |
Why?
|
| Embolization, Therapeutic | 2 | 2017 | 79 | 0.120 |
Why?
|
| Quadriplegia | 1 | 2013 | 11 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 2115 | 0.110 |
Why?
|
| Status Epilepticus | 1 | 2013 | 22 | 0.110 |
Why?
|
| Hypertension | 1 | 2019 | 913 | 0.110 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2012 | 19 | 0.110 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2012 | 43 | 0.110 |
Why?
|
| Craniocerebral Trauma | 1 | 2012 | 56 | 0.110 |
Why?
|
| Disease Progression | 3 | 2010 | 572 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2012 | 66 | 0.100 |
Why?
|
| Anesthetics, Local | 1 | 2012 | 77 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 375 | 0.100 |
Why?
|
| Central Cord Syndrome | 1 | 2010 | 2 | 0.100 |
Why?
|
| Point Mutation | 1 | 2010 | 23 | 0.100 |
Why?
|
| Neuroradiography | 1 | 2010 | 1 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 47 | 0.100 |
Why?
|
| Radiation Oncology | 1 | 2010 | 10 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 493 | 0.090 |
Why?
|
| Cerebral Infarction | 1 | 2010 | 24 | 0.090 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2010 | 20 | 0.090 |
Why?
|
| Young Adult | 5 | 2017 | 2413 | 0.090 |
Why?
|
| Angioplasty | 1 | 2010 | 32 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2010 | 20 | 0.090 |
Why?
|
| Interdisciplinary Communication | 1 | 2010 | 53 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2010 | 62 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 727 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 244 | 0.090 |
Why?
|
| Spinal Cord Diseases | 1 | 2009 | 12 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2010 | 124 | 0.090 |
Why?
|
| Sarcoidosis | 1 | 2009 | 27 | 0.090 |
Why?
|
| Angiography | 1 | 2009 | 75 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2020 | 3129 | 0.080 |
Why?
|
| Prognosis | 1 | 2013 | 1366 | 0.080 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2008 | 8 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2010 | 163 | 0.080 |
Why?
|
| Vasospasm, Intracranial | 1 | 2008 | 13 | 0.080 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2008 | 24 | 0.080 |
Why?
|
| Lumbar Vertebrae | 1 | 2009 | 98 | 0.080 |
Why?
|
| Brain | 2 | 2013 | 930 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2010 | 231 | 0.080 |
Why?
|
| Mass Screening | 2 | 2007 | 225 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2010 | 307 | 0.080 |
Why?
|
| Specimen Handling | 1 | 2007 | 31 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2010 | 283 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2007 | 504 | 0.070 |
Why?
|
| Trauma, Nervous System | 1 | 2005 | 6 | 0.070 |
Why?
|
| Rats, Wistar | 1 | 2005 | 84 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2005 | 59 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2017 | 480 | 0.070 |
Why?
|
| Reaction Time | 1 | 2005 | 121 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2005 | 281 | 0.060 |
Why?
|
| Palaemonidae | 1 | 2004 | 1 | 0.060 |
Why?
|
| Phylogeny | 1 | 2004 | 58 | 0.060 |
Why?
|
| American Heart Association | 2 | 2014 | 84 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2005 | 264 | 0.060 |
Why?
|
| Orbit | 2 | 2020 | 17 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 481 | 0.050 |
Why?
|
| Craniofacial Dysostosis | 1 | 2002 | 6 | 0.050 |
Why?
|
| Intracranial Hypertension | 1 | 2002 | 20 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2004 | 251 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2002 | 36 | 0.050 |
Why?
|
| Craniosynostoses | 1 | 2002 | 59 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 981 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2012 | 78 | 0.050 |
Why?
|
| Rats | 1 | 2005 | 1607 | 0.050 |
Why?
|
| Sphenoid Bone | 1 | 2020 | 3 | 0.050 |
Why?
|
| Length of Stay | 2 | 2012 | 294 | 0.050 |
Why?
|
| Titanium | 1 | 2020 | 9 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2020 | 46 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2016 | 2030 | 0.040 |
Why?
|
| Canada | 1 | 2017 | 49 | 0.040 |
Why?
|
| International Cooperation | 1 | 2017 | 25 | 0.040 |
Why?
|
| China | 1 | 2017 | 44 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2017 | 3 | 0.040 |
Why?
|
| Base Sequence | 2 | 2010 | 242 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 337 | 0.040 |
Why?
|
| Publishing | 1 | 2017 | 57 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2017 | 267 | 0.040 |
Why?
|
| Animals | 2 | 2005 | 7317 | 0.040 |
Why?
|
| Colonoscopy | 2 | 2007 | 41 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 160 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 21 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2016 | 164 | 0.030 |
Why?
|
| Obesity | 1 | 2002 | 1068 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 70 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 3729 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2014 | 149 | 0.030 |
Why?
|
| Skull Base Neoplasms | 1 | 2012 | 3 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 199 | 0.030 |
Why?
|
| Scotland | 1 | 2012 | 1 | 0.030 |
Why?
|
| Scalp | 1 | 2012 | 33 | 0.030 |
Why?
|
| Skull | 1 | 2012 | 45 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 293 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 142 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2012 | 170 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 871 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 67 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 66 | 0.020 |
Why?
|
| Specialty Boards | 1 | 2010 | 9 | 0.020 |
Why?
|
| Certification | 1 | 2010 | 24 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 45 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 354 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 62 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2010 | 119 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 190 | 0.020 |
Why?
|
| Curriculum | 1 | 2010 | 196 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2008 | 51 | 0.020 |
Why?
|
| Adenomatous Polyps | 1 | 2007 | 9 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 3554 | 0.020 |
Why?
|
| Patient Participation | 1 | 2007 | 62 | 0.020 |
Why?
|
| Guaiac | 1 | 2006 | 1 | 0.020 |
Why?
|
| Immunologic Tests | 1 | 2006 | 5 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2006 | 15 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 533 | 0.020 |
Why?
|
| Fresh Water | 1 | 2004 | 4 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2004 | 4 | 0.020 |
Why?
|
| Base Pairing | 1 | 2004 | 4 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2004 | 15 | 0.020 |
Why?
|
| Geography | 1 | 2004 | 34 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 28 | 0.010 |
Why?
|
| Forehead | 1 | 2002 | 10 | 0.010 |
Why?
|
| Frontal Bone | 1 | 2002 | 14 | 0.010 |
Why?
|
| Parietal Bone | 1 | 2002 | 12 | 0.010 |
Why?
|
| Papilledema | 1 | 2002 | 12 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 204 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2002 | 53 | 0.010 |
Why?
|
| Recurrence | 1 | 2002 | 235 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 974 | 0.010 |
Why?
|